Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.24.2.u1
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   42,445,517    
Beginning balance at Dec. 31, 2022 $ 100,999 $ 424 $ 360,155 $ (259,580)
Increase (Decrease) in Stockholders' Equity        
Net loss (13,734)     (13,734)
Stock-based compensation 8,344   8,344  
Issuance of restricted and performance stock units (in shares)   296,378    
Issuance of restricted and performance stock units 0 $ 4 (4)  
Exercise of stock options and employee stock purchase plan (in shares)   237,646    
Exercise of stock options and employee stock purchase plan 1,543 $ 2 1,541  
Ending balance (in shares) at Jun. 30, 2023   42,979,541    
Ending balance at Jun. 30, 2023 97,152 $ 430 370,036 (273,314)
Beginning balance (in shares) at Mar. 31, 2023   42,809,994    
Beginning balance at Mar. 31, 2023 97,513 $ 428 363,739 (266,654)
Increase (Decrease) in Stockholders' Equity        
Net loss (6,660)     (6,660)
Stock-based compensation 5,390   5,390  
Issuance of restricted and performance stock units (in shares)   57,659    
Issuance of restricted and performance stock units 0 $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   111,888    
Exercise of stock options and employee stock purchase plan 909 $ 1 908  
Ending balance (in shares) at Jun. 30, 2023   42,979,541    
Ending balance at Jun. 30, 2023 $ 97,152 $ 430 370,036 (273,314)
Beginning balance (in shares) at Dec. 31, 2023 43,124,496 43,124,496    
Beginning balance at Dec. 31, 2023 $ 95,665 $ 431 376,530 (281,296)
Increase (Decrease) in Stockholders' Equity        
Net loss (8,556)     (8,556)
Stock-based compensation 7,826   7,826  
Issuance of restricted and performance stock units (in shares)   583,386    
Issuance of restricted and performance stock units 0 $ 6 (6)  
Exercise of stock options and employee stock purchase plan (in shares)   116,856    
Exercise of stock options and employee stock purchase plan $ 752 $ 1 751  
Ending balance (in shares) at Jun. 30, 2024 43,824,738 43,824,738    
Ending balance at Jun. 30, 2024 $ 95,687 $ 438 385,101 (289,852)
Beginning balance (in shares) at Mar. 31, 2024   43,687,729    
Beginning balance at Mar. 31, 2024 93,156 $ 437 380,650 (287,931)
Increase (Decrease) in Stockholders' Equity        
Net loss (1,921)     (1,921)
Stock-based compensation 3,907   3,907  
Issuance of restricted and performance stock units (in shares)   44,153    
Issuance of restricted and performance stock units 0 $ 0 0  
Exercise of stock options and employee stock purchase plan (in shares)   92,856    
Exercise of stock options and employee stock purchase plan $ 545 $ 1 544  
Ending balance (in shares) at Jun. 30, 2024 43,824,738 43,824,738    
Ending balance at Jun. 30, 2024 $ 95,687 $ 438 $ 385,101 $ (289,852)